Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium sa-nv - bovine parainfluenza virus 3 (inactivated) ; bovine respiratory syncytial virus (inactivated) ; mannheimia haemolytica (inactivated) - suspension for injection - bovine respiratory syncytial virus (brsv); parainfluenza-3 virus; mannheimia haemolytica, inactivated - inactivated viral and inactivated bacterial vaccines - cattle

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium sa-nv - bovine parainfluenza virus 3 (inactivated) ; bovine respiratory syncytial virus (inactivated) ; mannheimia haemolytica (inactivated) ; bovine viral diarrhea virus (inactivated) - suspension for injection - bovine respiratory syncytial virus (brsv); parainfluenza-3 virus; bovine virus diarrhea (bvd); mannheimia haemolytica, inactivated - inactivated viral and inactivated bacterial vaccines - cattle

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios hipra s.a. - histophilus somni (inactivated) ; mannheimia haemolytica (inactivated, free of cells) > 2,8 elisa u/dose - emulsion for injection - histophilus somni, inactivated; mannheimia haemolytica, inactivated - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - cattle

Israel - English - Ministry of Health

beit-erez havat milatin ltd - gamithromycin - solution for injection - gamithromycin 150 mg/ml - * cattle: therapeutic and preventive treatment (metaphylaxis) of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni.the presence of the disease in the herd should be established before preventive treatment. * pigs (swine): treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida and haemophilus parasuis. * sheep:treatment of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus and fusobacterium necrophorum requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

virbac s.a. - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

ceva santé animale - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

vetoquinol - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

elanco gmbh - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

vmd n.v. - tulathromycin - antibacterials for systemic use, macrolides - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

animal health distributors limited - bovine parainfluenza virus 3, bovine respiratory syncytial virus, mannheimia haemolytica - suspension for injection - inactivated viral and bacterial vaccine - cattle